Archive

The campaign aimed to address the life-stage fears and concerns of people with MS

Mar 1-15, 2014 Feb 16-28, 2014 Feb 1-15, 2014 Jan 16-31, 2014 Jan 1-15, 2014 Dece 16-31, 2013 Dece 1-15, 2013 Nove 16-30,…

Chandavarkar has been the Chief Operating Officer of Biocon since 2006

Has over 27 years of experience in the pharmaceutical and biotech sector

Kuhnert to join Merck Executive Board on August 1, 2014

Zykadia (ceritinib) demonstrates an overall response rate of 54.6 per cent in patients with ALK+ metastatic NSCLC

Abbott announced initial results that suggest its innovative testing platform, known as IRIDICA (currently in development),…

As per data compiled by the PRS Legislative Research, the highest number of pending bills in the Rajya Sabha, 11, are from the…

US FDA has already banned the import of generic drugs from its two plants in India

Bhavik Narsana, Partner, Sameer Sah, Principal Associate and Arijeet Mukherjee, Associate, Khaitan & Co aim to identify the…